Chris Tame
Company: Ternary Therapeutics
Job title: Chief Executive Officer
Seminars:
Leveraging Computational Approaches for the Discovery & Optimisation of Molecular Glues 1:00 pm
day: Day 2, Track 2, PM
Chair’s Opening Remarks 8:30 am
day: Day Two Until 10am
PANEL DISCUSSION Clear Skies or Stormy Seas: Sailing the European Markets in Search of Funding & Partnerships for Effective Degrader Development 9:45 am
day: Day Two Until 10am